These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6714395)

  • 1. Effect of fenofibrate on heparin-induced lipidemic changes in hemodialyzed patients.
    Ferlito S; La Spina E; Indelicato G; Di Vincenzo S; Del Campo F; Fichera C
    Farmaco Prat; 1984 Mar; 39(3):87-90. PubMed ID: 6714395
    [No Abstract]   [Full Text] [Related]  

  • 2. Morphometric study of human hepatic cell modifications induced by fenofibrate.
    Gariot P; Barrat E; Drouin P; Genton P; Pointel JP; Foliguet B; Kolopp M; Debry G
    Metabolism; 1987 Mar; 36(3):203-10. PubMed ID: 3821501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lipidemic effect of calcium heparin in arteriosclerotic subjects.
    Ferlito S; Ricceri M; Platania M; Romano C; Zammataro M
    Panminerva Med; 1988; 30(4):257-61. PubMed ID: 3244481
    [No Abstract]   [Full Text] [Related]  

  • 4. The role of heparin in the changes of lipid patterns during a single hemodialysis.
    Teraoka J; Matsui N; Nakagawa S; Takeuchi J
    Clin Nephrol; 1982 Feb; 17(2):96-9. PubMed ID: 6802545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-tern effect of hemodialysis without heparin on abnormal lipid metabolism in patients on regular dialysis treatment (author's transl)].
    Matsui N; Shinoda T; Akiba T; Yoshiyama N; Nakagawa S; Takeuchi J; Teraoka J
    Nihon Jinzo Gakkai Shi; 1981 Sep; 23(9):1225-32. PubMed ID: 7328898
    [No Abstract]   [Full Text] [Related]  

  • 6. Uricosuric effect of fenofibrate in healthy volunteers.
    Desager JP; Hulhoven R; Harvengt C
    J Clin Pharmacol; 1980 Oct; 20(10):560-4. PubMed ID: 7440763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hemodialysis on plasma kinetics of fenofibrate in chronic renal failure.
    Desager JP; Costermans J; Verberckmoes R; Harvengt C
    Nephron; 1982; 31(1):51-4. PubMed ID: 7110477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
    Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
    ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of procetofen on serum lipids and apoproteins.
    Capurso A; Mogavero AM; Taverniti R; Resta F; Pace L; Bonomo L
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):194-7. PubMed ID: 6715088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic heparinization of uremic patients and its effects on blood lipids and on in vitro toxicity of the plasma.
    Wessel-Aas T; Christophersen B
    Clin Nephrol; 1982 Sep; 18(3):135-40. PubMed ID: 7140025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the type of membrane and heparin on serum lipid parameters during a dialysis session: a pilot study.
    Katopodis KP; Elisaf M; Balafa O; Nikolopoulos P; Bairaktari E; Katsaraki A; Siamopoulos KC
    Am J Nephrol; 2004; 24(5):469-73. PubMed ID: 15345918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.
    Harvengt C; Heller F; Desager JP
    Artery; 1980; 7(1):73-82. PubMed ID: 7247733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of long-term treatment with fenofibrate on serum lipids and lipoproteins in patients with hypercholesterolemia and hypertriglyceridemia].
    Sznajderman M
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1633-7. PubMed ID: 3588382
    [No Abstract]   [Full Text] [Related]  

  • 14. Plasma lipid concentrations and lecithin: cholesterol acyltransferase activity in normolipidemic subjects given fenofibrate and colestipol.
    Heller F; Desager JP; Harvengt C
    Acta Cardiol Suppl; 1981; 27():103-6. PubMed ID: 6977973
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of fenofibrate on the lipid level in diabetic patients].
    Häring HU; Schleicher E; Renner R; Mehnert H
    MMW Munch Med Wochenschr; 1983 Sep; 125(35):751-3. PubMed ID: 6415427
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in plasma activities of lipolytic enzymes and lipids of normolipidemic subjects given phenobarbital, a strong microsomal inducer, alone or in combination with fenofibrate.
    Heller FR; Desager JP; Harvengt C
    Int J Clin Pharmacol Ther Toxicol; 1988 Mar; 26(3):138-42. PubMed ID: 3410596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prothrombin time in long-term hemodialyzed patients. The effect of a single hemodialysis, heparin, protamine and vitamin K].
    Koslík S; Ponist J; Takác M; Lapsanská I
    Cas Lek Cesk; 1983 Feb; 122(5):139-42. PubMed ID: 6831493
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of low-dose fenofibrate treatment in diabetic rats with early onset nephropathy and established nephropathy.
    Kadian S; Mahadevan N; Balakumar P
    Eur J Pharmacol; 2013 Jan; 698(1-3):388-96. PubMed ID: 23085026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspects of cholesterol metabolism in normal and hypercholesterolemic Syrian hamsters. Influence of fenofibrate.
    Plancke MO; Olivier P; Clavey V; Marzin D; Fruchart JC
    Methods Find Exp Clin Pharmacol; 1988 Sep; 10(9):575-9. PubMed ID: 3226223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on the lipoprotein metabolism--changes of lipids, lipoprotein and apolipoprotein after heparin-induced lipolysis (author's transl)].
    Hara T
    Nihon Naika Gakkai Zasshi; 1974 Jun; 63(6):547-56. PubMed ID: 4373511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.